Nashville VA Medical Center

Nashville, Tennessee 37212-2637

4 studies enrolling now · 14 studies all time

What they study most

Acute Kidney Injury, COPD, Cardiovascular Diseases, Cognitive Impairment, Mild, Dementia, Fatigue, HIV Infections, HIV/AIDS, Multiple Sclerosis, Proteinuric Kidney Disease, Pulmonary Tuberculosis, Tuberculosis

Studies at this site

• Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1-Mediated Proteinuric Kidney Disease — Recruiting now
• A Patient-centered Trial of a Process-of-care Intervention in Hospitalized AKI Patients: the COPE-AKI Trial — Recruiting now
• Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults — Recruiting now
• Confirmatory Trial for Alleviating Fatigue in Multiple Sclerosis — Recruiting now
• TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment — Completed
• High-quality COPD Care for People With Immune Dysfunction Through Proactive E-consults — Completed
• TBTC Study 23C: Pharmacokinetics of Intermittent Rifabutin and Isoniazid With Daily Efavirenz — Completed
• TBTC Study 24: Intermittent Treatment of TB With Isoniazid Resistance or Intolerance — Completed
• TBTC Study 25: Study of the Tolerability of Higher Doses of Rifapentine in the Treatment of Tuberculosis — Completed
• TBTC Study 23A: Pharmacokinetics of Intermittent Isoniazid and Rifabutin in HIV-TB — Completed
• TBTC Study 25PK: Intensive Pharmacokinetic Study of Three Doses of Rifapentine and 25-Desacetyl Rifapentine — Completed
• TBTC Study 22: Efficacy of Once-Weekly Rifapentine and Isoniazid in Treatment of Tuberculosis — Completed
• TBTC Study 23B:Intensive PK of the Nelfinavir Rifabutin Interaction in Patients With HIV-TB — Completed
• TBTC Study 23: Treatment of HIV-Related Tuberculosis Using a Rifabutin-Based Regimen — Completed